Use of Cripto-1 as a biomarker for neurodegenerative disease and method of inhibiting progression thereof

Details for Australian Patent Application No. 2004278782 (hide)

Owner University of Kansas Medical Center Government Of The United States Of America represented by The Secretary, Department Of Health And Human Services

Inventors Berman, Nancy; Salomon, David; Stephens, Edward

Agent Fisher Adams Kelly

Pub. Number AU-A-2004278782

PCT Pub. Number WO2005/033341

Priority 60/508,750 03.10.03 US

Filing date 1 October 2004

Wipo publication date 14 April 2005

International Classifications

C12Q 1/68 (2006.01) Measuring or testing processes involving enzymes or micro-organisms - involving nucleic acids

Event Publications

30 March 2006 PCT application entered the National Phase

  PCT publication WO2005/033341 Priority application(s): WO2005/033341

30 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004278795-A cashflow funding system

2004278780-Oxygen scavenging compositions and methods of use